New findings suggest oxidative imbalance in the blood could signal Alzheimer’s risk years before symptoms, reinforcing the role of antioxidants and lifestyle choices in prevention.
By yourNEWS Media Newsroom
A growing body of research suggests that Alzheimer’s disease may begin silently years before memory loss appears — and that early biological warning signs could be detected through a routine blood test.
Researchers at the Institut National de la Recherche Scientifique (INRS) have identified evidence that an imbalance between oxidative stress and antioxidant defenses in the blood may serve as an early indicator of sporadic Alzheimer’s disease, the most common form of dementia. Their findings, published in Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, indicate that specific oxidative markers can be detected up to five years before a clinical diagnosis.
The team focused on plasma extracellular vesicles, microscopic particles released by cells throughout the body, including brain cells. These vesicles carry molecular signals that reflect internal cellular processes. Elevated oxidative markers in these particles were associated with future Alzheimer’s diagnoses, suggesting that neurodegenerative changes may be detectable well before symptoms emerge.
The discovery represents a shift from current diagnostic practices, which typically rely on cognitive testing, advanced brain imaging, or spinal fluid analysis after symptoms are already present. Researchers emphasized that “once the disease is symptomatic, it is difficult, if not impossible, to reverse it,” underscoring the importance of earlier identification.
At the center of the findings is oxidative stress — a condition in which harmful free radicals overwhelm the body’s natural antioxidant defenses. Oxidative stress is considered one of the earliest biological events in Alzheimer’s pathology, contributing to damage in brain cells long before memory impairment becomes apparent.
Antioxidants act as counterweights to this process, neutralizing free radicals and helping preserve cellular function. Additional evidence from a long-term study conducted by the National Institutes of Health supports this connection. That research followed 7,283 adults for an average of 16 years and found that individuals with higher blood levels of certain antioxidants were less likely to develop dementia later in life.
“Extending people’s cognitive functioning is an important public health challenge,” said study author Dr. May A. Beydoun of the National Institute on Aging. “Antioxidants may help protect the brain from oxidative stress, which can cause cell damage.”
However, the protective effect was not uniform across all antioxidant types. The NIH study found that higher blood levels of carotenoids — specifically lutein, zeaxanthin and beta-cryptoxanthin — were associated with reduced dementia risk. Lutein and zeaxanthin are commonly found in leafy green vegetables such as kale and spinach, while beta-cryptoxanthin is present in fruits like oranges and papaya.
In contrast, blood levels of vitamins A, C and E did not show the same consistent association with lower dementia risk in that study. The distinction suggests that the source and type of antioxidant may matter, and that obtaining these compounds through whole foods could provide advantages not replicated by supplementation alone.
A broader review of research has concluded that antioxidants derived from natural dietary sources may help delay the onset and progression of Alzheimer’s disease. Scientists note that the brain is particularly vulnerable to oxidative damage due to its high metabolic activity and fat content, making nutritional patterns a potentially significant factor in long-term cognitive health.
Current Alzheimer’s treatments remain limited. Available medications may temporarily ease symptoms but do not halt the underlying neurodegenerative process. As a result, attention has increasingly shifted toward prevention and early detection.
Less than one percent of Alzheimer’s cases are attributed to rare genetic mutations. For the vast majority, risk is influenced by a combination of environmental and lifestyle factors. Public health experts estimate that addressing modifiable risk factors — including cardiovascular health, diabetes, physical inactivity and poor diet — could prevent more than one-third of global Alzheimer’s cases.
Researchers caution that while the proposed blood test requires further validation before routine clinical use, the findings reinforce a broader scientific message: Alzheimer’s disease is not solely predetermined by genetics. Biological changes may begin in midlife or earlier, and dietary patterns rich in specific antioxidants may play a role in shaping long-term cognitive resilience.
The emerging evidence suggests that the choices individuals make decades before symptoms appear — particularly in diet and overall metabolic health — may influence the trajectory of brain aging in measurable ways.
Source: Natural News
Original article
Comments